Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: The histological criteria in the 1999 and 2008 scoring systems proposed by the International Autoimmune Hepatitis Group (IAIHG) have their inherent limitations in diagnosing autoimmune hepatitis (AIH). In this study, we evaluated the histology components of four scoring systems (1. revised original scoring system [“1999 IAIHG”], 2. simplified scoring system [“2008 IAIHG”], 3. modified histologic criteria [“2017 UCSF”], and 4. a new histologic criteria proposed by the International AIH Pathology Group [“2022 IAHPG”]) in AIH patients. Methods: Medical records and liver biopsies were retrospectively reviewed for 68 patients from two independent medical institutions, diagnosed with AIH based on the 1999 IAIHG system between 2006 and 2016. The histological features were reviewed in detail, and the four histological scoring systems were compared. Results: Out of the 68 patients, 56 (82.4%) patients met the “probable” or “definite” AIH criteria of the 2008 IAIHG system, and the proportion of histologic score 2 (maximum) was 40/68 (58.8%). By applying the 2017 UCSF criteria, the number of histology score 2 increased to 60/68 (88.2%), and “probable” or “definite” AIH cases increased to 61/68 (89.7%). Finally, applying the 2022 IAHPG histology score resulted in the highest number of cases with histologic score 2 (64/68; 94.1%) and with a diagnosis of “probable” or “definite” AIH (62/68; 91.2%). Conclusions: The recently proposed UCSF/IAHPG histological criteria increased the histology score of AIH. Substituting the histology component of the 2008 IAIHG system with the 2022 IAHPG criteria increased the sensitivity for diagnosing AIH (≥“Probable AIH”) from 82.4% to 91.2%.
Abstract
Background/Aims: The histological criteria in the 1999 and 2008 scoring systems proposed by the International Autoimmune Hepatitis Group (IAIHG) have their inherent limitations in diagnosing autoimmune hepatitis (AIH). In this study, we evaluated the histology components of four scoring systems (1. revised original scoring system [“1999 IAIHG”], 2. simplified scoring system [“2008 IAIHG”], 3. modified histologic criteria [“2017 UCSF”], and 4. a new histologic criteria proposed by the International AIH Pathology Group [“2022 IAHPG”]) in AIH patients. Methods: Medical records and liver biopsies were retrospectively reviewed for 68 patients from two independent medical institutions, diagnosed with AIH based on the 1999 IAIHG system between 2006 and 2016. The histological features were reviewed in detail, and the four histological scoring systems were compared. Results: Out of the 68 patients, 56 (82.4%) patients met the “probable” or “definite” AIH criteria of the 2008 IAIHG system, and the proportion of histologic score 2 (maximum) was 40/68 (58.8%). By applying the 2017 UCSF criteria, the number of histology score 2 increased to 60/68 (88.2%), and “probable” or “definite” AIH cases increased to 61/68 (89.7%). Finally, applying the 2022 IAHPG histology score resulted in the highest number of cases with histologic score 2 (64/68; 94.1%) and with a diagnosis of “probable” or “definite” AIH (62/68; 91.2%). Conclusions: The recently proposed UCSF/IAHPG histological criteria increased the histology score of AIH. Substituting the histology component of the 2008 IAIHG system with the 2022 IAHPG criteria increased the sensitivity for diagnosing AIH (≥“Probable AIH”) from 82.4% to 91.2%.
참고문헌 (26)
- Heo NY, "Epidemiology and updated management for autoimmune liver disease", Clin Mol Hepatol, 29, pp.194~196 (2023)
- Manns MP, "Autoimmune hepatitis--Update 2015", J Hepatol, 62(1 Suppl), pp.S100~S111 (2015)
- Alvarez F, "International Autoimmune Hepatitis Group Report : review of criteria for diagnosis of autoimmune hepatitis", J Hepatol, 31, pp.929~938 (1999)
- Hennes EM, "Simplified criteria for the diagnosis of autoimmune hepatitis", Hepatology, 48, pp.169~176 (2008)
- Johnson PJ, "Meeting report : International Autoimmune Hepatitis Group", Hepatology, 18, pp.998~1005 (1993)
- Korean Association for the Study of the Liver(KASL), "KASL clinical practice guidelines for management of autoimmune hepatitis 2022", Clin Mol Hepatol, 29, pp.542~592 (2023)
- Balitzer D, "Autoimmune hepatitis : review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria", Mod Pathol, 30, pp.773~783 (2017)
- Lohse AW, "Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group : Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology : Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology", Liver Int, 42, pp.1058~1069 (2022)
- Ishak K, "Histological grading and staging of chronic hepatitis", J Hepatol, 22, pp.696~699 (1995)
- Batts KP, "Chronic hepatitis. An update on terminology and reporting", Am J Surg Pathol, 19, pp.1409~1417 (1995)
- Hennes EM, "Mycophenolate mofetil as second line therapy in autoimmune hepatitis?", Am J Gastroenterol, 103, pp.3063~3070 (2008)
- Wiegard C, "Scoring systems for the diagnosis of autoimmune hepatitis : past, present, and future", Semin Liver Dis, 29, pp.254~261 (2009)
- Gatselis NK, "Autoimmune hepatitis, one disease with many faces : etiopathogenetic, clinico-laboratory and histological characteristics", World J Gastroenterol, 21, pp.60~83 (2015)
- Yeoman AD, "Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group(IAIHG)criteria in acute and chronic liver disease", Hepatology, 50, pp.538~545 (2009)
- Iwai M, "Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis", Hepatol Res, 38, pp.784~789 (2008)
- Washington MK, "Autoimmune liver disease : overlap and outliers", Mod Pathol, 20(Suppl 1), pp.S15~S30 (2007)
- Tsutsui A, "Histopathological analysis of autoimmune hepatitis with"acute"presentation : Differentiation from druginduced liver injury", Hepatol Res, 50, pp.1047~1061 (2020)
- Gurung A, "Histologic features of autoimmune hepatitis : a critical appraisal", Hum Pathol, 82, pp.51~60 (2018)
- Miao Q, "Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis", Clin Rev Allergy Immunol, 48, pp.226~235 (2015)
- Suzuki A, "The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury", Hepatology, 54, pp.931~939 (2011)
- de Boer YS, "Assessment of the histopathological key features in autoimmune hepatitis", Histopathology, 66, pp.351~362 (2015)
- Kumari N, "Significance of histopathological features in differentiating autoimmune liver disease from nonautoimmune chronic liver disease in children", Eur J Gastroenterol Hepatol, 25, pp.333~337 (2013)
- Tucker SM, "Hyaline droplets in Kupffer cells : a novel diagnostic clue for autoimmune hepatitis", Am J Surg Pathol, 39, pp.772~778 (2015)
- Himoto T, "The pathological appearance of hyaline droplets in Kupffer cells is not specific to patients with autoimmune hepatitis", Int J Clin Exp Pathol, 10, pp.8703~8708 (2017)
- Khedr MA, "Kupffer cell hyaline globules in children with autoimmune hepatitis", J Clin Exp Hepatol, 12, pp.20~28 (2022)
- Franceschini T, "A practical histological approach to the diagnosis of autoimmune hepatitis : experience of an Italian tertiary referral center", Virchows Arch, 479, pp.937~945 (2021)